Royce & Associates’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
657,080
-383,793
| -37% | -$837K | 0.01% | 640 |
|
|
2025
Q1 | $2.84M | Buy |
1,040,873
+241,000
| +30% | +$658K | 0.03% | 533 |
|
|
2024
Q4 | $3.33M | Buy |
799,873
+475,949
| +147% | +$1.98M | 0.03% | 552 |
|
|
2024
Q3 | $1.26M | Buy |
323,924
+121,272
| +60% | +$472K | 0.01% | 697 |
|
|
2024
Q2 | $794K | Buy |
202,652
+121,224
| +149% | +$475K | 0.01% | 746 |
|
|
2024
Q1 | $341K | Sell |
81,428
-245,910
| -75% | -$1.03M | ﹤0.01% | 812 |
|
|
2023
Q4 | $1.54M | Sell |
327,338
-95,222
| -23% | -$448K | 0.01% | 685 |
|
|
2023
Q3 | $1.32M | Buy |
422,560
+23,780
| +6% | +$74.2K | 0.01% | 702 |
|
|
2023
Q2 | $1.83M | Buy |
398,780
+90,855
| +30% | +$417K | 0.02% | 674 |
|
|
2023
Q1 | $1.52M | Buy |
307,925
+37,800
| +14% | +$187K | 0.02% | 711 |
|
|
2022
Q4 | $1.47M | Buy |
270,125
+48,800
| +22% | +$266K | 0.02% | 696 |
|
|
2022
Q3 | $1.44M | Buy |
221,325
+108,325
| +96% | +$704K | 0.02% | 675 |
|
|
2022
Q2 | $534K | Sell |
113,000
-1,131,272
| -91% | -$5.35M | 0.01% | 828 |
|
|
2022
Q1 | $8.7M | Sell |
1,244,272
-59,049
| -5% | -$413K | 0.07% | 407 |
|
|
2021
Q4 | $13.3M | Sell |
1,303,321
-109,243
| -8% | -$1.11M | 0.1% | 317 |
|
|
2021
Q3 | $17.2M | Buy |
+1,412,564
| New | +$17.2M | 0.13% | 243 |
|